共 14 条
[1]
D'Marco L(2020)Diabetic kidney disease and COVID-19: the crash of two pandemics Front Med (Lausanne) 7 199-1099
[2]
Tang N(2020)Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy J Thromb Haemost 18 1094-833
[3]
Leung C(2020)Clinical features of deaths in the novel coronavirus epidemic in China Rev Med Virol 30 823-1629
[4]
Holman N(2020)Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study Lancet Diabetes Endocrinol 8 1623-416
[5]
Cai R(2021)Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis Int Urol Nephrol 53 403-c184
[6]
Leon-Abarca JA(2020)The impact of COVID-19 in diabetic kidney disease and chronic kidney disease: a population-based study Acta Biomed 91 c179-2257
[7]
Baden LR(2021)Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine N Engl J Med 384 6121-241
[8]
Khwaja A(2012)KDIGO clinical practice guidelines for acute kidney injury Nephron Clin Pract 120 47-77
[9]
Galiero R(2022)Association between renal function at Admission and COVID-19 in-hospital mortality in Southern Italy: findings from the prospective multicenter Italian COVOCA study J Clin Med 11 2251-838
[10]
Jeong HE(2023)Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study BMC Med 21 230-undefined